SCHEMBL844746

SCHEMBL844746

Nc1ncccc1-c1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
LMNA P02545 3/20 0.54
CCR1 P32246 2/20 0.54
CCR5 P51681 2/20 0.54
CCR8 P51685 2/20 0.54
CYP1A2 P05177 1/20 0.54
POLB P06746 1/20 0.54
METAP1 P53582 1/20 0.54
BLM P54132 1/20 0.54
HIF1A Q16665 1/20 0.54
DOHH Q9BU89 1/20 0.54
P4HTM Q9NXG6 1/20 0.54
TDO2 P48775 1/20 0.52
MAP4K4 O95819 1/20 0.48
ALOX15 P16050 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
NPC1 O15118 6/20 0.46
RAB9A P51151 5/20 0.46
TP53 P04637 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30802290 1.00 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL10062975 0.81 MAP4K4 (0.59) KDM4ELMNACCR1CCR5CCR8
SCHEMBL858806 0.81 KDM4E (0.72) KDM4ELMNACCR1CCR5CCR8
SCHEMBL819951 0.80 KDM4E (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29450625 0.80 KDM4E (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30423127 0.79 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL11901991 0.79 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30968134 0.79 MAP4K4 (0.57) KDM4ELMNACCR1CCR5CCR8
SCHEMBL12853975 0.79 KDM4E (0.68) KDM4ELMNACCR1CCR5CCR8
SCHEMBL12853986 0.79 KDM4E (0.68) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023115327-A1 PYRIDO RING COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATION 中国药科大学 2023-06-29 WO disclosed
EP-4126844-A1 AMIDE COMPOUNDS AND USES THEREOF Hutchison Medipharma Limited (CN) 2023-02-08 EP disclosed
CN-114466840-A acetyl-CoA synthetase 2(ACSS2) inhibitors and methods of use thereof 威斯达研究所 2022-05-10 CN disclosed
WO-2021197276-A1 Amide compounds and uses thereof HUTCHISON MEDIPHARMA LIMITED (CN) 2021-10-07 WO disclosed
EP-3185328-A1 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2017-06-28 EP disclosed
CN-105153119-A Pyridylpyrimidyl amine compounds or pyridylpyridyl amine compounds and application thereof GUANGZHOU KEQIN NEW MEDICINE DESIGN CO LTD 2015-12-16 CN disclosed
CN-105153119-A Pyridylpyrimidyl amine compounds or pyridylpyridyl amine compounds and application thereof GUANGZHOU KEQIN NEW MEDICINE DESIGN CO LTD 2015-12-16 CN disclosed
CN-103391934-A Dipyridylamine Derivatives DAIICHI SANKYO CO LTD 2013-11-13 CN disclosed
EP-2082005-B9 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT LLC (US) 2013-05-22 EP disclosed
EP-2082005-B1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT LLC (US) 2012-08-01 EP disclosed
CN-102325773-A 6-ring amino-2,3-bipyridyl imidazo [1,2-b]-pyridazine derivatives and preparation thereof and treatment are used SANOFI AVENTIS 2012-01-18 CN disclosed
CN-102083829-A Improved Raf inhibitors GPC BIOTECH AG 2011-06-01 CN disclosed
CN-101616917-A Pyrido [2,3-D] pyrimidine and they are as the purposes of kinase inhibitor GPC BIOTECH INC 2009-12-30 CN disclosed
EP-2082005-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS Pleotint, L.L.C. (US) 2009-07-29 EP disclosed
US-7542196-B2 Ligand exchange thermochromic, (LETC), systems PLEOTINT, L.L.C. (US) 2009-06-02 US disclosed
US-7525717-B2 reversible; laminated; transition metal ion coordinated with a high epsilon ligand and a low epsilon ligand; polymer; separator; variable light transmission windows; polyvinyl butyral; nickel or cobalt iodide ligands; diol, triol or polyol ligands PLEOTINT, L.L.C. (US) 2009-04-28 US disclosed
US-20080105851-A1 Exhibiting a reversible change in absorbance of electromagnetic radiation as the temperature of the system is reversibly changed; comprising a transition metal ion and a ligand PLEOTINT, LLC (US) 2008-05-08 US disclosed
US-20080100903-A1 MULTI-LAYER LIGAND EXCHANGE THERMOCHROMIC SYSTEMS PLEOTINT, LLC (US) 2008-05-01 US disclosed
US-20080100902-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT, LLC (US) 2008-05-01 US disclosed
WO-2008028128-A1 LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS PLEOTINT, L.L.C. (US) 2008-03-06 WO disclosed